Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.09 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |